Emerging Countries Take Note: Big Pharma's Losing Patent Battles In India
Linkedin

Emerging Countries Take Note: Big Pharma's Losing Patent Battles In India

Chennai : India | Oct 05, 2012 at 3:36 AM PDT
Source: Tech Dirt
XX XX
Views: Pending
 
Naturally, the patent holder, Bayer, fought back, and appealed against that decision. German pharma major Bayer AG, seeking a stay on an order of India's Controller of Patents granting a compulsory licence (CL) to Indian generic drug maker Natco Pharma Limited, for a drug used to treat liver and kidney... FULL ARTICLE AT Tech Dirt
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
  • Credibility
  • Wait... Flag
 
 
Advertisement
 

News Stories

 
  • Pfizer to appeal over India patent refusal

      China Post
    U.S. drug giant Pfizer said Friday it will appeal against an Indian ruling overturning a patent for a cancer drug, saying the decision sparks questions about intellectual property protection in India. Indian generics drugs heavyweight Cipla teamed up...

More From Allvoices

Most Commented Reports



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.